Here, we identify EphA5 as a molecular target of lung cancer and as a novel regulator of IR-induced cell cycle checkpoint and DNA damage repair, with unexpected roles in the resistance of lung cancer to radiotherapy. Here, EPHA5 is linked to lung carcinoma.